UNSPSC 51111700: Antineoplastic antibiotics

This classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called ANTI-NEOPLASTICS, ANTINEOPLASTICS, or ANTINEOPLASTIC ANTIBIOTICS.

UNSPSC 51111700 Antineoplastic antibiotics, a Class code, covers chemotherapy agents derived from or functioning as antibiotics used in cancer treatment protocols. State and local procurement activity under this code focuses on purchasing bulk quantities of specific drug formulations—including doxorubicin, daunorubicin, bleomycin, and mitomycin C—for use in hospital oncology departments, cancer treatment centers, and integrated health systems operated by county and municipal authorities. These purchases typically occur through competitive bid processes managed by hospital procurement offices, county health departments, and state Medicaid agencies acting as group purchasing administrators. Issuing bodies range from large urban hospital systems to smaller regional medical centers and state health facility networks, many of which leverage group purchasing organization (GPO) contracts or cooperative purchasing frameworks to standardize pricing and ensure reliable supply chains for cancer care programs.

The source provided contains no recent state or local contract opportunities under this code and does not identify specific jurisdictions, issuing bodies, response dates, or representative solicitations. Without posted RFP, RFQ, IFB, or ITB activity in the data, no geographic concentration or current market activity can be characterized.